Referenzen
*Okabe, K., Yaku, K., Uchida, Y., Fukamizu, Y., Sato, T., Sakurai, T., Tobe, K., & Nakagawa, T. (2022). Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. Frontiers in nutrition, 9, 868640. https://doi.org/10.3389/fnut.2022.868640
**Igarashi, M., Nakagawa-Nagahama, Y., Miura, M. et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging 8, 5 (2022). https://doi.org/10.1038/s41514-022-00084-z
***Piper, R., Carr, P.J., Kelsey, L.J. et al. The mechanistic causes of peripheral intravenous catheter failure based on a parametric computational study. Sci Rep 8, 3441 (2018). https://doi.org/10.1038/s41598-018-21617-1
Fukamizu, Y., Uchida, Y., Shigekawa, A. et al. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep 12, 14442 (2022). https://doi.org/10.1038/s41598-022-18272-y